以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 讯飞医疗科技股份有限公司是一家主要从事提供人工智能赋能的医疗解决方案的中国公司。基层医疗服 务业务线由智医助理及慢病管理组成。医院服务业务线包括智慧医院解决方案和诊疗助理。患者服务业 务线包括智慧医院患者服务与诊后管理（包括讯飞晓医App及小程序）、影像云平台以及医疗器械。区 域管理平台解决方案业务线包括智慧卫生解决方案和智慧医保。该公司主要在国内市场开展业务。 证券之星消息，2月26日南向资金减持4000.0股讯飞医疗科技（02506.HK）。近5个交易日中，获南向资 金增持的有3天，累计净增持8.58万股。近20个交易日中，获南向资金增持的有10天，累计净增持5.79万 股。截至目前，南向资金持有讯飞医疗科技（02506.HK）520.72万股，占公司已发行普通股的6.73%。 ...

Core Viewpoint - The article discusses the recent trading activity of iFlytek Medical Technology (02506.HK), highlighting the fluctuations in southbound capital holdings and the company's focus on AI-enabled healthcare solutions [1] Group 1: Southbound Capital Activity - On February 13, southbound capital increased its holdings in iFlytek Medical Technology by 19,500 shares [1] - Over the past five trading days, there were three days of net reductions, totaling 283,600 shares [1] - In the last 20 trading days, there were ten days of net increases, amounting to 40,700 shares [1] - Currently, southbound capital holds 5,154,200 shares of iFlytek Medical Technology, representing 6.66% of the company's issued ordinary shares [1] Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled healthcare solutions in China [1] - The company's business lines include grassroots medical services (intelligent medical assistants and chronic disease management), hospital services (smart hospital solutions and diagnostic assistants), and patient services (smart hospital patient services and post-discharge management) [1] - The company also offers regional management platform solutions, including smart health solutions and smart medical insurance [1] - iFlytek Medical Technology mainly operates in the domestic market [1]

近期事件 经济观察网讯飞医疗科技(02506.HK)近期有多项动态值得关注，包括主要股东延长股份禁售期、中标重 要国家项目、受益于行业政策以及技术商业化进展。 2025年12月29日，公司主要股东(包括科大讯飞（002230）股份有限公司、科讯创投等)主动将原定于 2025年12月29日到期的禁售期延长一年，至2026年12月29日止。期间，这些股东承诺不减持公司股份， 合计持有H股比例达68.25%(占总股本72.86%)。这一举措被视为对公司长期发展的信心体现，可能有助 于稳定市场预期。 公司项目推进 业绩经营情况 尽管2025年上半年营收同比增长30.26%至2.99亿元，净亏损收窄42.86%，但参考资料显示，2025年全年 医疗大模型订单集中落地可能提升盈利确定性。投资者可关注公司后续财务报告对订单转化和盈利能力 的披露。 以上内容基于公开资料整理，不构成投资建议。 根据国家卫生健康委等部门政策，如《关于促进和规范"人工智能+医疗卫生"应用发展的实施意见》， AI医疗赛道在2026年预计迎来大规模应用浪潮。讯飞医疗作为基层医疗AI解决方案的领先企业，可能 持续受益于政策驱动下的订单增长和市场扩张。 ...

Core Viewpoint - Southbound funds increased their holdings in iFlytek Medical Technology (02506.HK) by 13,400 shares on February 12, indicating a fluctuating interest from investors in the company [1] Group 1: Southbound Fund Activity - Over the past five trading days, there were three days of net reductions in holdings, totaling a decrease of 227,900 shares [1] - In the last twenty trading days, there were ten days of net increases, with a total increase of 326,000 shares [1] - As of now, southbound funds hold 5,134,800 shares of iFlytek Medical Technology, representing 6.63% of the company's total issued ordinary shares [1] Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services (comprising intelligent medical assistants and chronic disease management), hospital services (including smart hospital solutions and diagnostic assistants), and patient services (such as smart hospital patient services and post-discharge management) [1] - The regional management platform solutions business line includes smart health solutions and smart medical insurance [1]

Core Insights - The launch of the Spark X2 model by iFlytek marks a significant advancement in domestic computing power and capabilities, particularly in AI health services [1] - The Spark X2 model achieves international standards in core competencies such as mathematics, reasoning, and language understanding, with a 50% improvement in inference performance compared to its predecessor [1] - The iFlytek Xiaoyi AI health assistant has accumulated over 180 million AI health consultations, achieving a user satisfaction rate of 98% [2] Group 1: Technological Advancements - The Spark X2 model utilizes a 293B MoE sparse architecture, enabling efficient deployment on domestic platforms and enhancing overall performance [1] - The model's capabilities in multiple languages have improved, maintaining industry leadership in key languages for regions like Latin America and ASEAN [1] - The Spark Medical Model X2 has surpassed competitors like DeepSeek V3.2 in key tasks such as health analysis and report interpretation [1] Group 2: Product Upgrades - The iFlytek Xiaoyi has transitioned from an "AI consultation tool" to an "AI health steward," offering a comprehensive digital health space for users [2] - The upgraded app includes features for multi-round consultations, report interpretation, and chronic disease management, while ensuring user privacy [2] - The "Smart Family Doctor" model enhances the efficiency of grassroots family doctors through intelligent task arrangement and health profiling [2] Group 3: Industry Impact - The upgrade signifies a deeper integration of AI in healthcare, contributing to the construction of a healthier China by improving access to quality medical resources [2]

Core Insights - The launch of the Spark X2 model by iFlytek represents a significant advancement in domestic computing power and capabilities, particularly in the healthcare sector [1][2] - The Spark X2 model achieves international-level performance in core competencies such as mathematics, reasoning, and language understanding, with a 50% improvement in inference performance compared to its predecessor [1] - iFlytek's AI health assistant, iFlytek Xiaoyi, has accumulated over 180 million AI health consultations with a user satisfaction rate of 98%, showcasing its effectiveness and user acceptance [2] Group 1: Spark X2 Model - The Spark X2 model is based on fully domestic computing power training, marking a dual breakthrough in both domestic capabilities and core competencies [1] - The model employs a 293B MoE sparse architecture, enabling efficient deployment on domestic platforms and enhancing overall performance [1] - It has been evaluated by the Shanghai Medical Model Application Testing and Verification Center, receiving an "A" rating in multiple health service tasks, indicating its professional advantages and compliance [1] Group 2: iFlytek Xiaoyi Upgrade - The upgrade of iFlytek Xiaoyi transforms it from an "AI consultation tool" to an "AI health steward," enhancing its service capabilities significantly [2] - The app now supports comprehensive health management for family members, including features like voice interaction, detailed report interpretation, and chronic disease management [2] - The innovative "Smart Family Doctor" model empowers grassroots family doctors, improving service efficiency and enhancing residents' sense of well-being [2]

企查查APP显示，近日，北京讯飞随医科技有限公司成立，法定代表人为陈祖吉，注册资本为1000万元，经营范围包含：第二类医疗器械销售； 人工智能硬件销售；人工智能应用软件开发；远程健康管理服务等。企查查股权穿透显示，该公司由科大讯飞（002230）旗下讯飞医疗科技股份 有限公司全资持股。 相关ETF (产品代码: 516630) ★ 跟踪： 中证云计算与大数据主题指数 创业板人工智能ETF 科创人工智能ETF华 ke 員 (产品代码: 159381) (产品代码: 589010) ★ 跟踪:创业板人工智能指数收益率 ★ 跟踪：上证科创板人工智能指数 近五日涨跌:5.95% 近五日涨跌: -1.16% 资金流向: 最新份额为15.8亿份,减少 市盈率: 88.60倍 了2100.0万份,净申 资金流向: 最新份额为9.2亿份, 减少 座-3497.3 厅元。 了600.0万份,净申 赎-1283.4万元。 估值分位:78.67% 通信ETF华夏 (产品代码: 515050) ★ 跟踪：中证5G通信主题指数 近五日涨跌: - 1.84% 市盈率: 51.82倍 资金流向: 最新份额为35.1亿份,减少 了1400. ...

Group 1 - Tencent Holdings (00700) had a net inflow of 4.316 billion, representing a 22.17% increase in net inflow ratio [2][3] - Alibaba-W (09988) experienced a net inflow of 1.658 billion, with a net inflow ratio of 13.70% [2][3] - Pop Mart (09992) saw a net inflow of 588 million, with a net inflow ratio of 17.52% [2][3] Group 2 - Kangfang Biotech (09926) faced a net outflow of -285 million, with a net outflow ratio of -33.89% [2][3] - Yingfu Fund (02800) had a net outflow of -248 million, with a net outflow ratio of -1.88% [2][3] - Yum China (09987) recorded a net outflow of -213 million, with a net outflow ratio of -30.90% [2][3] Group 3 - Huaxia Hang Seng Technology (03088) led in net inflow ratio at 89.30% with a net inflow of 54.532 million [2][3] - Southern East Selection (03441) followed with a net inflow ratio of 68.86% and a net inflow of 14.5209 million [2][3] - China Foods (00506) had a net inflow ratio of 59.26% with a net inflow of 4.9995 million [2][3] Group 4 - Jinyuan International (02232) had the highest net outflow ratio at -50.27% with a net outflow of -40.079 million [3] - iFlytek Medical Technology (02506) recorded a net outflow ratio of -49.63% with a net outflow of -15.2262 million [3] - Sinopec Crown (00934) had a net outflow ratio of -45.08% with a net outflow of -5.1472 million [3]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in iFlytek Medical Technology (02506.HK) by 186,500 shares on February 10, 2026, marking a decrease of 3.44% [1][2] - Over the past five trading days, there have been four days of reductions in holdings, totaling a net decrease of 210,700 shares [1] - In the last 20 trading days, there were 11 days of increased holdings, with a cumulative net increase of 1,308,000 shares [1] Group 2 - As of now, southbound funds hold 5,231,600 shares of iFlytek Medical Technology, which represents 6.76% of the company's total issued ordinary shares [1] - The company primarily engages in providing AI-powered medical solutions, with business lines including grassroots medical services, hospital services, patient services, and regional management platform solutions [2] - The grassroots medical services line consists of intelligent medical assistants and chronic disease management, while the hospital services line includes smart hospital solutions and diagnostic assistance [2]

Core Viewpoint - The southbound capital has increased its holdings in iFlytek Medical Technology (02506.HK), indicating growing investor interest in the company, particularly in the context of its AI-enabled healthcare solutions [1][2]. Group 1: Shareholding Changes - On February 6, 2026, southbound capital increased its holdings by 75,200 shares, representing a 1.40% increase [2]. - Over the past five trading days, there were two days of net increases, totaling 140,300 shares [1]. - In the last 20 trading days, there were 12 days of net increases, amounting to 1,661,200 shares [1]. Group 2: Current Shareholding Status - As of February 6, 2026, southbound capital holds 5,437,800 shares of iFlytek Medical Technology, which accounts for 7.02% of the company's total issued ordinary shares [1][2]. Group 3: Company Overview - iFlytek Medical Technology is primarily engaged in providing AI-enabled healthcare solutions in China, with business lines including grassroots medical services, hospital services, patient services, and regional management platform solutions [2].